Additionally, S&P affirmed the “BBB” rating on Eastern Maine Healthcare System’s series 2016B bonds, affecting $79.5 million of debt.
The outlook was revised to negative from stable, reflecting S&P’s uncertainty regarding EMHS’ ability to reverse its historically weaker operating performance.
“The negative outlook reflects challenged underlying operating performance at several EMHS hospitals including its flagship, Eastern Maine Medical Center and multi-yearsystem performance, which has been below expectations,” said Cynthia Keller, an S&P Global Ratings credit analyst.
S&P also acknowledged the health system’s positive year-to-date operating and net earnings.
More articles on healthcare finance:
Quorum Health sees net loss narrow to $30.6M, plans more hospital sales
Chinese billionaire again ups stake in CHS — this time for $71M
Auditor: 15-bed Missouri hospital at heart of $90M billing fraud scheme
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
